D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.9B |
| 2 |
Broadcom
AVGO
|
+$1.07B |
| 3 |
NVIDIA
NVDA
|
+$908M |
| 4 |
Meta Platforms (Facebook)
META
|
+$861M |
| 5 |
Intuitive Surgical
ISRG
|
+$666M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.68B |
| 2 |
Apple
AAPL
|
+$1.31B |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$789M |
| 4 |
GE Aerospace
GE
|
+$653M |
| 5 |
Applovin
APP
|
+$634M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.25% |
| 2 | Consumer Discretionary | 7.51% |
| 3 | Financials | 7.11% |
| 4 | Healthcare | 6.95% |
| 5 | Industrials | 6.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TDACU
2376
Translational Development Acquisition Corp Units
TDACU
| $3.64M | ﹤0.01% |
350,000
| – | – |
|
2377
Yext
YEXT
$552M
| $3.64M | ﹤0.01% |
427,051
-437,072
| -51% | -$3.71M |
|
2378
PUT
Emcor
EME
$35.7B
| $3.64M | ﹤0.01% |
5,600
+600
| +12% | +$364K |
|
2379
Afya
AFYA
$1.31B
| $3.64M | ﹤0.01% |
233,159
-71,900
| -24% | -$1.1M |
|
2380
CALL
Viking Therapeutics
VKTX
$3.84B
| $3.64M | ﹤0.01% |
138,400
+114,900
| +489% | +$3.43M |
|
2381
CALL
RH
RH
$3.15B
| $3.64M | ﹤0.01% |
17,900
-113,900
| -86% | -$24.7M |
|
2382
PUT
Valaris
VAL
$5.23B
| $3.63M | ﹤0.01% |
74,400
+1,600
| +2% | +$78K |
|
2383
Kanzhun
BZ
$7.33B
| $3.63M | ﹤0.01% |
155,293
+79,491
| +105% | +$1.71M |
|
2384
CALL
Constellation Brands
STZ
$22.3B
| $3.62M | ﹤0.01% |
26,900
-19,400
| -42% | -$3.09M |
|
2385
Tango Therapeutics
TNGX
$4.49B
| $3.62M | ﹤0.01% |
+430,379
| New | +$2.91M |
|
|
VRE
2386
DELISTED
Veris Residential
VRE
| $3.61M | ﹤0.01% |
237,798
-226,599
| -49% | -$3.37M |
|
2387
Medifast
MED
$110M
| $3.6M | ﹤0.01% |
263,648
-57,581
| -18% | -$804K |
|
2388
CALL
IMAX
IMAX
$2.61B
| $3.6M | ﹤0.01% |
110,000
| – | – |
|
|
EMA
2389
CALL
Emera Inc
EMA
$16.6B
| $3.6M | ﹤0.01% |
75,000
| – | – |
|
2390
Regions Financial
RF
$26.3B
| $3.6M | ﹤0.01% |
136,399
-1,942,462
| -93% | -$50.5M |
|
|
TDAC
2391
Translational Development Acquisition Corp
TDAC
$209M
| $3.59M | ﹤0.01% |
346,900
| – | – |
|
2392
Kornit Digital
KRNT
$695M
| $3.59M | ﹤0.01% |
265,656
-21,183
| -7% | -$360K |
|
2393
PUT
Marathon Petroleum
MPC
$91.7B
| $3.58M | ﹤0.01% |
18,600
-4,100
| -18% | -$721K |
|
2394
CALL
KeyCorp
KEY
$24.2B
| $3.58M | ﹤0.01% |
+191,700
| New | +$3.55M |
|
2395
CALL
GeneDx Holdings
WGS
$2.05B
| $3.58M | ﹤0.01% |
33,200
+1,000
| +3% | +$109K |
|
2396
GCM Grosvenor
GCMG
$751M
| $3.57M | ﹤0.01% |
295,945
-11,696
| -4% | -$145K |
|
2397
Costamare
CMRE
$1.87B
| $3.56M | ﹤0.01% |
299,186
+113,426
| +61% | +$1.24M |
|
2398
PUT
Samsara
IOT
$20.9B
| $3.56M | ﹤0.01% |
95,500
+49,500
| +108% | +$1.84M |
|
2399
Dave & Buster's
PLAY
$377M
| $3.56M | ﹤0.01% |
195,820
-115,769
| -37% | -$3.04M |
|
2400
PUT
Pagaya Technologies
PGY
$1.47B
| $3.55M | ﹤0.01% |
119,700
+77,700
| +185% | +$2.51M |
|
Similar funds
D.E. Shaw & Co's Q3 2025 Portfolio in Review
As of Q3 2025, D.E. Shaw & Co held 5,023 positions worth $177B, up 26% from $141B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
D.E. Shaw & Co deployed $15.2B of net new capital in Q3 2025, opening 714 new positions and adding to 1,743 existing holdings. Its largest new stake was iShares iBoxx $ Investment Grade Corporate Bond ETF: 3,319,000 shares worth $370M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 16% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.68B trimmed.
- D.E. Shaw & Co's largest Q3 2025 buy was iShares iBoxx $ Investment Grade Corporate Bond ETF: 3,319,000 shares worth $370M.
- D.E. Shaw & Co added most to Microsoft in Q3 2025, an estimated $1.9B increase.
- D.E. Shaw & Co's biggest Q3 2025 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.68B.
- D.E. Shaw & Co fully exited Hess in Q3 2025, selling an estimated $527M.
- D.E. Shaw & Co's ten largest holdings make up 13% of its $177B portfolio in Q3 2025.
- D.E. Shaw & Co opened 714 new positions and closed 514 in Q3 2025.
- D.E. Shaw & Co's portfolio value rose 26% quarter-over-quarter to $177B.
Based on D.E. Shaw & Co's 13F filing for Q3 2025, filed 14 Nov 2025.